Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation

• 1. 奈莫利珠单抗对具有中至重度表皮脱落的异位性皮炎的治疗 [P] . 中国专利： CN112040976A . 2020-12-04
• 2. 贝兰他单抗莫福汀与派姆单抗组合用于治疗癌症 [P] . 中国专利： CN113924317A . 2022-01-11
• 3. NEMOLIZUMAB IN TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION [P] . RU2758378C1 . 2021-10-28

  机译： Nemolizumab治疗特应性皮炎，中度至重度概念

• 4. Nemolizumab in the treatment of atopic dermatitis with moderate to severe excoriation [P] . AU2019219608A1 . 2020-08-27

  机译： 奈莫珠单抗治疗特发性皮炎伴中重度severe除

• 5. NEMOLIZUMAB IN THE TREATMENT OF ATOPIC DERMATITIS WITH MODERATE TO SEVERE EXCORIATION [P] . SG11202007558YA . 2020-09-29

  机译： 尼莫珠单抗在中度至重度中度治疗原子性皮肤炎中的作用

• 1. Recent advances of TCM treatment of childhood atopic dermatitis [J] . 徐薇薇, 蔡玲玲, 张历元, 世界中西医结合杂志（英文） . 2017,第003期
• 2. Recent advances of TCM treatment of childhood atopic dermatitis [J] . Xu Weiwei, Cai Lingling, Zhang Liyuan, 世界中西医结合杂志（英文） . 2017,第003期
• 3. Recent advances of TCM treatment of childhood atopic dermatitis [J] . 徐薇薇1, 蔡玲玲2, 张历元2, 世界中西医结合杂志（英文） . 2017,第3)期
• 4. The clinical value of dynamic ultrasound measurement of optic nerve sheath diameter in the treatment of patients with moderate and severe craniocerebral injury [J] . Li-Na Xian, Xiao-Yan Deng, Xian Liang, 海南医科大学学报（英文版） . 2021,第013期
• 5. The clinical value of dynamic ultrasound measurement of optic nerve sheath diameter in the treatment of patients with moderate and severe craniocerebral injury [J] . Li-Na Xian, Xiao-Yan Deng, Xian Liang, 海南医科大学学报(英文版) . 2021,第013期
• 6. Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus [J] . Silverberg Jonathan I, Pinter Andreas, Pulka Grazyna, The Journal of Allergy and Clinical Immunology . 2020,第1期
• 7. Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II II study [J] . Mihara Ryosuke, Kabashima Kenji, Furue Masutaka, The Journal of dermatology . 2019,第8期
• 8. Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study [J] . Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, The Journal of Allergy and Clinical Immunology . 2018,第4期
• 9. MEDICAL TREATMENT OF PRURITUS AND ATOPIC DERMATITIS [C] . Douglas J. DeBoer Conference of the American Animal Hospital Association(2013 :Phoenix(US)) . 2014
• 10. Topical Probiotics in the Treatment of Atopic Dermatitis: A Randomized Controlled Trial [D] . Chen, Jessica. 2018
• 11. Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study [O] . Ryosuke Mihara, Kenji Kabashima, Masutaka Furue, -1
• 12. Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study [O] . Kenji Kabashima, Masutaka Furue, Jon M. Hanifin, 2018

• 1. 紫杉醇联合曲妥珠单抗和帕妥珠单抗方案治疗HER-2(+)转移性乳腺癌的Ⅱ期临床试验 [C] . 巴雅巴尔 ,殷凯 ,陆劲松 . 第四届上海浦东乳腺癌高峰论坛 . 2016
• 2. 雷珠单抗治疗非增生性2型特发性黄斑毛细血管扩张症疗效的Meta分析 [A] . 杨腾 . 2018